Akili is marketing its latest digital therapeutic in an over-the-counter version to adults with ADHD. (Akili)

Amid AD­HD drug short­age, Ak­ili aims for adults with over-the-counter video game treat­ment

Ak­ili In­ter­ac­tive’s launch of an over-the-counter ver­sion of its video game treat­ment ar­rives at a time when many peo­ple with AD­HD are strug­gling to get ac­cess to Adder­all and re­lat­ed med­ica­tions that are in short sup­ply.

The com­pa­ny’s En­deav­orOTC for adults launched on Wednes­day amid the on­go­ing AD­HD drug short­age that has pa­tients scram­bling to find med­ica­tions like Adder­all in ad­di­tion to gener­ic Ri­tal­in and Con­cer­ta and law­mak­ers de­mand­ing so­lu­tions from the FDA, Drug En­force­ment Ad­min­is­tra­tion and drug­mak­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.